author-photo

Vanessa Offrete

French Institute of Health and Medical Research

11

Papers

2

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Abstract 988: F14512, a novel vectorized topoiserase II inhibitor, bypasses MDR1 mediated resistance.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 2747: Synergistic antileukemic activity of F14512 in combination with AraC

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3518: In vitro and in vivo synergistic effects of F14512, a novel targeted cytotoxic agent in phase I clinical study, in combination with other anticancer drugs

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract A214: F14512, a novel targeted cytotoxic agent exhibits a marked antileukemic activity, alone and in combination with AraC.

2011 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Establishment and characterization of a human A549 non small cell lung cancer cell line resistant to the novel vectorized cytotoxic drug F14512

2008 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Tumor cell-selective DNA damaging activity of the targeted cytotoxic agent F14512

2007 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
F14512, a novel targeted cytotoxic agent with a potent and selective antiproliferative activity against cancer cells expressing a high level of polyamine transport system

2007 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
On the mechanism of action of triptolide, beyond the NF-kB pathway

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
Combination of NF-κB inhibitors with anticancer drugs: Synergism or antagonism?

2004 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)